Virtual-reality Exercises for Alleviating Attention Deficits in Patients with Acquired Brain Injury
Launched by MINDMAZE SA · Feb 14, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of virtual reality exercises to help improve attention and focus in patients who have experienced brain injuries, such as strokes. Attention problems are common after a stroke, affecting many survivors and making daily tasks challenging. The goal of the study is to see if fun, game-like exercises in a virtual reality setting can help patients regain their attention skills better than traditional exercises.
To be eligible for the trial, participants must be at least 18 years old and have had a stroke within the past month. They also need to show that they have difficulty with attention based on specific tests. However, individuals with certain conditions, like epilepsy or severe memory issues, cannot participate. If accepted, participants can expect to engage in interactive, gamified training sessions that aim to enhance their cognitive abilities in a supportive environment. This study is currently recruiting participants of all genders and aims to provide valuable insights into new ways to support recovery after brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Time from stroke onset \< 1 month
- • Objective pathological performance on at least one standardized test or subtest on attention during standard neuropsychological evaluation
- • Brain injury documented by routine neuroradiological examination (computed tomography or magnetic resonance imaging scan)
- • Able to give informed consent as documented by signature
- • Age \>= 18 years old
- Exclusion Criteria:
- • Epilepsy
- • Inability or contraindications to undergo the investigated intervention
- • Major psychiatric co-morbidity
- • Major neurocognitive deficits (e.g. dementia)
- • Incapacity to discriminate colors
- • General cognitive state preventing to understand and perform the tasks
- • Decision to not be informed of incidental findings
About Mindmaze Sa
MindMaze SA is a pioneering neurotechnology company dedicated to transforming the way neurological disorders are diagnosed and treated. By integrating advanced virtual reality, motion capture, and artificial intelligence, MindMaze develops innovative therapeutic solutions that enhance patient outcomes in rehabilitation and cognitive health. With a strong commitment to research and development, the company collaborates with leading academic institutions and healthcare providers to advance clinical trials and bring cutting-edge therapies to market, ultimately improving the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lausanne, , Switzerland
Patients applied
Trial Officials
Sonia Crottaz-Herbette
Principal Investigator
University of Lausanne Hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials